Home › Arrhythmogenic Right Ventricular Dysplasia › New York
Arrhythmogenic Right Ventricular Dysplasia clinical trials in New York
4 studies for Arrhythmogenic Right Ventricular Dysplasia are looking for participants at sites in New York.
Cardiovascular Multimodality Imaging Study
- Montefiore Health System, The Bronx
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 10, 2026 · NCT06610019A Study to Assess Real-world Patient Characteristics and Clinical Course for Symptomatic Patients With PKP2-ACM
- University of Rochester, Rochester
RecruitingObservational study
Ages 18 to 65 · All sexes · Updated May 16, 2025 · NCT06976606Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC
- NYU Langone Health, New York
RecruitingPhase 1
Ages 18 to 65 · All sexes · Updated Feb 6, 2025 · NCT06228924Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
- New York University, New York
RecruitingObservational study
Ages 14 to 65 · All sexes · Updated Nov 1, 2024 · NCT06311708From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.